Search Results - "Nishiwaki, Yutaka"

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma by Mok, Tony S, Wu, Yi-Long, Thongprasert, Sumitra, Yang, Jin-Ji, Yang, Chih-Hsin, Chu, Da-Tong, Saijo, Nagahiro, Sunpaweravong, Patrapim, Han, Baohui, Margono, Benjamin, Ichinose, Yukito, Nishiwaki, Yutaka, Ohe, Yuichiro, Chewaskulyong, Busyamas, Jiang, Haiyi, Duffield, Emma L, Watkins, Claire L, Armour, Alison A, Fukuoka, Masahiro

“…This trial compared gefitinib, an inhibitor of the tyrosine kinase of epidermal growth factor (EGFR), with carboplatin plus paclitaxel as initial treatment of…”
Get full text

Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer by MARUYAMA, Riichiroh, NISHIWAKI, Yutaka, TAKEDA, Koji, INOUE, Akira, TOMII, Keisuke, HARADA, Masao, MASUDA, Noriyuki, HAIYI JIANG, ITOH, Yohji, ICHINOSE, Yukito, SAIJO, Nagahiro, FUKUOKA, Masahiro, TAMURA, Tomohide, YAMAMOTO, Nobuyuki, TSUBOI, Masahiro, NAKAGAWA, Kazuhiko, SHINKAI, Tetsu, NEGORO, Shunichi, IMAMURA, Fumio, EGUCHI, Kenji

“…This phase III study (V-15-32) compared gefitinib (250 mg/d) with docetaxel (60 mg/m(2)) in patients (N = 489) with advanced/metastatic non-small-cell lung…”
Get full text

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer by FUKUOKA, Masahiro, YANO, Seiji, EEK, Richard, HORAI, Takeshi, NODA, Kazumasa, TAKATA, Ichiro, SMIT, Egbert, AVERBUCH, Steven, MACLEOD, Angela, FEYEREISLOVA, Andrea, DONG, Rui-Ping, BASELGA, José, GIACCONE, Giuseppe, TAMURA, Tomohide, NAKAGAWA, Kazuhiko, DOUILLARD, Jean-Yves, NISHIWAKI, Yutaka, VANSTEENKISTE, Johan, KUDOH, Shinzoh, RISCHIN, Danny

“…To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor…”
Get full text

Patients' perception of the usefulness of a question prompt sheet for advanced cancer patients when deciding the initial treatment: a randomized, controlled trial by Shirai, Yuki, Fujimori, Maiko, Ogawa, Asao, Yamada, Yu, Nishiwaki, Yutaka, Ohtsu, Atsushi, Uchitomi, Yosuke

“…Objective: The objective of this study was to evaluate the patients' perception of the usefulness of a question prompt sheet (QPS) in facilitating the…”
Get full text

Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer by OHE, Yuichiro, ICHINOSE, Yukito, SAIJO, Nagahiro, FUKUOKA, Masahiro, NAKAGAWA, Kazuhiko, TAMURA, Tomohide, KUBOTA, Kaoru, YAMAMOTO, Nobuyuki, ADACHI, Susumu, NAMBU, Yoshihiro, FUJIMOTO, Toshio, NISHIWAKI, Yutaka

“…Purpose: The objective of this study was to evaluate the efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B 12 in…”
Get full text

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104 by TAKADA, Minoru, FUKUOKA, Masahiro, FUKUDA, Haruhiko, SAIJO, Nagahiro, KAWAHARA, Masaaki, SUGIURA, Takahiko, YOKOYAMA, Akira, YOKOTA, Soichiro, NISHIWAKI, Yutaka, WATANABE, Koshiro, NODA, Kazumasa, TAMURA, Tomohide

“…To evaluate the optimal timing for thoracic radiotherapy (TRT) in limited-stage small-cell lung cancer (LS-SCLC), the Lung Cancer Study Group of the Japan…”
Get full text

Mutational status of EGFR and KIT in thymoma and thymic carcinoma by Yoh, Kiyotaka, Nishiwaki, Yutaka, Ishii, Genichiro, Goto, Koichi, Kubota, Kaoru, Ohmatsu, Hironobu, Niho, Seiji, Nagai, Kanji, Saijo, Nagahiro

“…Summary This study was conducted to evaluate the prevalence of EGFR and KIT mutations in thymomas and thymic carcinomas as a means of exploring the potential…”
Get full text

Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness by Yamaguchi, Yoko, Ishii, Genichiro, Kojima, Motohiro, Yoh, Kiyotaka, Otsuka, Hajime, Otaki, Yoichi, Aokage, Keiju, Yanagi, Shingo, Nagai, Kanji, Nishiwaki, Yutaka, Ochiai, Atsushi

“…The term tumor budding has been applied to single cells or small clusters of up to four cells within the stromal tissue at the invasive margin of colorectal…”
Get more information

Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese by Shiraishi, Kouya, Kohno, Takashi, Kunitoh, Hideo, Watanabe, Shun-ichi, Goto, Koichi, Nishiwaki, Yutaka, Shimada, Yoko, Hirose, Hiroshi, Saito, Ikuo, Kuchiba, Aya, Yamamoto, Seiichro, Yokota, Jun

“…Recent genome wide association (GWA) studies on European and American populations revealed association with lung cancer risk of single-nucleotide polymorphisms…”
Get full text

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience by Yoshida, Junji, Nagai, Kanji, Yokose, Tomoyuki, Nishimura, Mitsuyo, Kakinuma, Ryutaro, Ohmatsu, Hironobu, Nishiwaki, Yutaka

“…This study was undertaken to determine the recurrence rate after limited resection of small lung carcinoma and to evaluate intraoperative frozen-section…”
Get full text

Breast Cancer Resistance Protein Impacts Clinical Outcome in Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer by YOH, Kiyotaka, ISHII, Genichiro, YOKOSE, Tomoyuki, MINEGISHI, Yuji, TSUTA, Kohji, GOTO, Koichi, NISHIWAKI, Yutaka, KODAMA, Tetsuro, SUGA, Moritaka, OCHIAI, Atsushi

“…Purpose: The purpose of this study was to investigate the relationship between the level of expression of ATP-binding cassette (ABC) transporter proteins, and…”
Get full text

First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study by NIHO, Seiji, KUBOTA, Kaoru, GOTO, Koichi, YOH, Kiyotaka, OHMATSU, Hironobu, KAKINUMA, Ryutaro, SAIJO, Nagahiro, NISHIWAKI, Yutaka

“…We conducted a phase II study of single agent treatment with gefitinib in chemotherapy-naïve patients with advanced non-small-cell lung cancer (NSCLC) to…”
Get full text

Hypertrophic pulmonary osteoarthropathy as a paraneoplastic manifestation of lung cancer by Ito, Takeo, Goto, Koichi, Yoh, Kiyotaka, Niho, Seiji, Ohmatsu, Hironobu, Kubota, Kaoru, Nagai, Kanji, Miyazaki, Eishi, Kumamoto, Toshihide, Nishiwaki, Yutaka

“…This study examined the frequency of hypertrophic pulmonary osteoarthropathy (HPO) and the clinical characteristics of lung cancer with HPO. The results of…”
Get more information

Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study by Kubota, Kaoru, MD, Kawahara, Masaaki, Dr, Ogawara, Mitsumasa, MD, Nishiwaki, Yutaka, MD, Komuta, Kiyoshi, MD, Minato, Koichi, MD, Fujita, Yuka, MD, Teramukai, Satoshi, PhD, Fukushima, Masanori, Prof, Furuse, Kiyoyuki, MD

“…Summary Background Platinum-containing two-drug combinations improve survival and cancer-related symptoms in patients with advanced non-small-cell lung cancer…”
Get full text

A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: the prognostic importance of the area of residual tumor by Yamane, Yuki, Ishii, Genichiro, Goto, Koichi, Kojima, Motohiro, Nakao, Masayuki, Shimada, Yoshihisa, Nishiwaki, Yutaka, Nagai, Kanji, Kohrogi, Hirotsugu, Ochiai, Atsushi

“…Histopathological evaluation method for predicting the outcome of non-small cell lung cancer (NSCLC) treated by neoadjuvant therapy has not been fully…”
Get more information

Vascular invasion is a strong prognostic factor after complete resection of node-negative non-small cell lung cancer by Naito, Yoichi, Goto, Koichi, Nagai, Kanji, Ishii, Genichiro, Nishimura, Mitsuyo, Yoshida, Junji, Hishida, Tomoyuki, Nishiwaki, Yutaka

“…The seventh edition of TNM classification for non-small cell lung cancer (NSCLC) has been approved. Vascular invasion has been reported as being a strong risk…”
Get more information

Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group by KUBOTA, Kaoru, WATANABE, Koshiro, YONEDA, Shuichi, MATSUI, Kaoru, KUDO, Shinzo, SHIBUYA, Masahiko, ISOBE, Takeshi, SEGAWA, Yoshihiko, NISHIWAKI, Yutaka, OHASHI, Yasuo, NIITANI, Hisanobu, KUNITOH, Hideo, NODA, Kazumasa, ICHINOSE, Yukito, KATAKAMI, Nobuyuki, SUGIURA, Takahiko, KAWAHARA, Masaaki, YOKOYAMA, Akira, YOKOTA, Soichiro

“…Few randomized trials have demonstrated survival benefit of combination chemotherapy involving new agents plus cisplatin compared with classic combination…”
Get full text

Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes by Kohno, Takashi, Kunitoh, Hideo, Shimada, Yoko, Shiraishi, Kouya, Ishii, Yuko, Goto, Koichi, Ohe, Yuichiro, Nishiwaki, Yutaka, Kuchiba, Aya, Yamamoto, Seiichiro, Hirose, Hiroshi, Oka, Akira, Yanagitani, Noriko, Saito, Ryusei, Inoko, Hidetoshi, Yokota, Jun

“…Adenocarcinoma (ADC) is the commonest histological type of lung cancer, and its weak association with smoking indicates the necessity to identify high-risk…”
Get full text

The impact on survival of positive intraoperative pleural lavage cytology in patients with non–small-cell lung cancer by Aokage, Keiju, MD, Yoshida, Junji, MD, Ishii, Genichiro, MD, Enatsu, Sotarou, MD, Hishida, Tomoyuki, MD, Nishimura, Mitsuyo, MD, Nishiwaki, Yutaka, MD, Nagai, Kanji, MD

“…Objective The aim of this study was to analyze intraoperative pleural lavage cytology results in patients with non–small-cell lung cancer and quantify the…”
Get full text

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases by Shiono, Satoshi, Ishii, Genichiro, Nagai, Kanji, Yoshida, Junji, Nishimura, Mitsuyo, Murata, Yukinori, Tsuta, Koji, Nishiwaki, Yutaka, Kodama, Tetsuro, Ochiai, Atsushi

“…Pulmonary metastasectomy is a standard method of treatment for selective pulmonary metastases of colorectal cancer. However, the pathologic factors of…”
Get full text